I have invested in AHZ primarily for the potential of the Adapt tissue platform over next 5 to 10 years. However, it's hard to not get a little excited about the impending unblinded HSV 2 phase 2 results due in the 4th quarter. I am sure most of you will have seen this clip but thought it was worth sharing again.
It shows some of the excitement generated at the start of the phase 1 trials. Yet here we are some time later eagerly awaiting the results of the phase 2 unblinded results (on the back of very promising blinded results). Not only that but hopefully we will see the HPV phase 1b trial (which will test for safety and importantly efficacy) kicked off by the end of the year generating similar excitement and media coverage. Sure invest for CC and the (surprising) infusion business but dare to imagine what's possible if our Professor Frazer nails the HSV 2 Herpes vacine.
Imagine what's possible - HSV 2
-
- There are more pages in this discussion • 150 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add AVR (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
$18.00 |
Change
-0.300(1.64%) |
Mkt cap ! $346.0M | |||
| Open | High | Low | Value | Volume |
| $18.29 | $18.30 | $17.65 | $181.7K | 10.18K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 30 | $17.72 |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| $18.00 | 499 | 1 |
View Market Depth
| Last trade - 16.10pm 05/07/2024 (20 minute delay) ? |
| AVR (ASX) Chart |